Skip to main navigation
Skip to search
Skip to main content
WashU Medicine Research Profiles Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
Interleukin-12 and tuberculosis: an old story revisited
Andrea M. Cooper
, Alejandra Solache
, Shabaana A. Khader
Department of Molecular Microbiology
Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
Institute of Clinical and Translational Sciences (ICTS)
COVID-19 Researchers
Research output
:
Contribution to journal
›
Review article
›
peer-review
133
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Interleukin-12 and tuberculosis: an old story revisited'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Interleukin-12 (IL-12)
100%
Tuberculosis
100%
Interleukin-27 (IL-27)
80%
Interleukin-23 (IL-23)
60%
Cellular Response
40%
Long-term Survival
20%
Inflammatory Response
20%
Tissue Damage
20%
Bacterial Killing
20%
Bacterial Control
20%
Interleukin-12 Family
20%
Immune Intervention
20%
Medicine and Dentistry
Interleukin 12
100%
Interleukin 27
80%
Interleukin 23
60%
Cytokine
20%
Serositis
20%
Long Term Survival
20%
Tissue Injury
20%
Bactericidal Activity
20%
Interleukin-12 Family
20%
Pharmacology, Toxicology and Pharmaceutical Science
Interleukin 12
100%
Interleukin 27
66%
Interleukin 23
50%
Cytokine
16%
Inflammation
16%
Tissue Injury
16%
Long Term Survival
16%
Nursing and Health Professions
Interleukin 12
100%
Interleukin 27
66%
Interleukin 23
50%
Long Term Survival
16%
Inflammation
16%
Tissue Injury
16%
Neuroscience
Interleukin 12
100%
Interleukin 27
66%
Interleukin 23
50%
Cytokine
16%